This passive 3% stake from a major asset manager is routine and adds to the institutional accumulation pattern seen in recent 13G filings. Monitor for any future conversion to a 13D filing, which would signal activist intent, but no such indication exists here.
YARW drugs
YARW drug pipeline →Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Janus Henderson Group Ltd. filed an amended Schedule 13G disclosing a 3.0% passive beneficial ownership stake in Yarrow Bioscience as of September 30, 2026, representing 283,341 shares. This is a new passive disclosure from a large asset manager, adding to a series of recent 13G filings by other institutions following Yarrow's September 2026 equity offering. The stake is below 5% and carries no activist intent.
Key Financial Metrics
Key Facts
- Janus Henderson Group Ltd. disclosed a 3.0% beneficial ownership stake in Yarrow Bioscience as of September 30, 2026
- The stake consists of 283,341 shares of common stock
- The filing is an amendment to Schedule 13G, indicating passive investment intent
- Janus Henderson is the ultimate parent of multiple SEC-registered investment advisers and foreign equivalents
- No single managed portfolio within Janus Henderson owns more than 5% of Yarrow Bioscience's common stock
Financial Impact
3.0% stake valued at approximately $5.5M based on $183M market cap
Risk Factors
- No material risks identified from this passive stake filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001274173-26-000261 |
| Document: Item_7.txt | 0001274173-26-000261 |
| Document: 0001274173-26-000261-index-headers.html | 0001274173-26-000261 |
| Document: 0001274173-26-000261-index.html | 0001274173-26-000261 |
| Document: 0001274173-26-000261.txt | 0001274173-26-000261 |
Track record
13 reports on YARW
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 17, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.27 +0.49% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Viewing Entry $15.44 Now $14.27 −7.58% settles Dec 15
- Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $18.20 Now $14.27 −21.59% settles Dec 15
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $17.35 Now $14.27 −17.75% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.27 −27.31% settles Dec 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers